Expert Perspectives in Metastatic Breast Cancer

EP. 1: Introduction: Impact of Molecular Subtyping in Breast Cancer

February 25th 2015

EP. 2: Role of Genetic Testing in Breast Cancer

February 25th 2015

EP. 3: Pathologist's Role in Genetic Testing for Breast Cancer

February 25th 2015

EP. 4: Reviewing Key Genomic Assays in Breast Cancer

February 25th 2015

EP. 5: Predicting Risk of Recurrence in Breast Cancer

February 25th 2015

EP. 6: Pathology, Oncology Collaboration in Breast Cancer

February 25th 2015

EP. 7: Genetic Tests Offer New Tool for Tumor Assessment

February 25th 2015

EP. 8: Treating ER-Positive De Novo Metastatic Breast Cancer

February 25th 2015

EP. 9: CDK4/6 Inhibition in Metastatic Breast Cancer

February 25th 2015

EP. 10: Endocrine Therapy Resistance in Breast Cancer

February 25th 2015

EP. 11: Role of Bevacizumab in Breast Cancer

February 25th 2015

EP. 12: BOLERO-2: Everolimus Plus Exemestane in Resistant MBC

February 25th 2015

EP. 13: Pertuzumab in HER2-Positive Metastatic Breast Cancer

February 25th 2015

EP. 14: Role of T-DM1 in HER2-Positive Breast Cancer

February 25th 2015

EP. 15: Managing Brain Metastases in Breast Cancer

February 25th 2015

EP. 16: Standard Therapies for Triple-Negative Breast Cancer

February 25th 2015

EP. 17: Chemotherapeutics for Triple-Negative Breast Cancer

February 25th 2015

EP. 18: Future Treatments for Triple-Negative Breast Cancer

February 25th 2015